Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Prinz Felix |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2024

Beiträge in Fachzeitschriften

** Jonas, K; Prinz, F; Ferracin, M; Krajina, K; Deutsch, A; Madl, T; Rinner, B; Slaby, O; Klec, C; Pichler, M MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B.
Noncoding RNA. 2023; 10(1): Doi: 10.3390/ncrna10010002 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kaptein, P; Slingerland, N; Metoikidou, C; Prinz, F; Brokamp, S; Machuca-Ostos, M; de, Roo, G; Schumacher, TNM; Yeung, YA; Moynihan, KD; Djuretic, IM; Thommen, DS CD8-targeted IL2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool.
Cancer Discov. 2024; Doi: 10.1158/2159-8290.CD-23-1263 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2023

** Jonas, K; Prinz, F; Ferracin, M; Krajina, K; Pasculli, B; Deutsch, A; Madl, T; Rinner, B; Slaby, O; Klec, C; Pichler, M MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib
BREAST CANCER RES. 2023; 25(1): 119 Doi: 10.1186/s13058-023-01716-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Mayr, C; Kiesslich, T; Bekric, D; Beyreis, M; Kittl, M; Ablinger, C; Neureiter, E; Pichler, M; Prinz, F; Ritter, M; Neureiter, D; Jakab, M; Dobias, H Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells
PLOS ONE. 2023; 18(6): Doi: 10.1371/journal.pone.0287769 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

** Balihodzic, A; Prinz, F; Dengler, MA; Calin, GA; Jost, PJ; Pichler, M Non-coding RNAs and ferroptosis: potential implications for cancer therapy.
Cell Death Differ. 2022; 29(6):1094-1106 Doi: 10.1038/s41418-022-00998-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klec, C; Knutsen, E; Schwarzenbacher, D; Jonas, K; Pasculli, B; Heitzer, E; Rinner, B; Krajina, K; Prinz, F; Gottschalk, B; Ulz, P; Deutsch, A; Prokesch, A; Jahn, SW; Lellahi, SM; Perander, M; Barbano, R; Graier, WF; Parrella, P; Calin, GA; Pichler, M ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Cell Mol Life Sci. 2022; 79(7): 391 Doi: 10.1007/s00018-022-04402-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Prinz, F; Jonas, K; Balihodzic, A; Klec, C; Reicher, A; Barth, DA; Riedl, J; Gerger, A; Kiesslich, T; Mayr, C; Rinner, B; Kargl, J; Pichler, M MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
RNA Biol. 2022; 19(1): 1305-1315. Doi: 10.1080/15476286.2022.2152978 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Balihodzic, A; Prinz, F; Jonas, K; Barth, DA; Dengler, MA; Slaby, O; Jost, PJ; Klec, C; Pichler, M A novel long non-coding RNA hypoxia associated-lncRNA1 is involved in cellular growth, apoptosis and patients’ prognosis in clear cell renal cell carcinoma.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2022; 15: 37-67.-OeGHO- & AHOP-Frühjahrstagung; APRIL 8-10, 2022; Graz, AUSTRIA. [Poster]
FullText

 

2021

Beiträge in Fachzeitschriften

** Balihodzic, A; Barth, DA; Prinz, F; Pichler, M Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer.
Cancers (Basel). 2021; 13(5): 977 Doi: 10.3390/cancers13050977 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Prinz, F; Balihodzic, A; Mayr, C; Kiesslich, T; Klec, C; Jonas, K; Barth, DA; Riedl, JM; Gerger, A; Pichler, M MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Cancers (Basel). 2021; 13(16): Doi: 10.3390/cancers13163996 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

** Barth, DA; Brenner, C; Riedl, JM; Prinz, F; Klocker, EV; Schlick, K; Kornprat, P; Lackner, K; Stöger, H; Stotz, M; Gerger, A; Pichler, M External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Cancer Med. 2020; 9(15):5473-5479 Doi: 10.1002/cam4.3233 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barth, DA; Prinz, F; Teppan, J; Jonas, K; Klec, C; Pichler, M Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer.
Noncoding RNA. 2020; 6(3): Doi: 10.3390/ncrna6030027 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klocker, EV; Barth, DA; Riedl, JM; Prinz, F; Szkandera, J; Schlick, K; Kornprat, P; Lackner, K; Lindenmann, J; Stöger, H; Stotz, M; Gerger, A; Pichler, M Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Cancers (Basel). 2020; 12(5): Doi: 10.3390/cancers12051154 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reicher, A; Harris, AL; Prinz, F; Kiesslich, T; Wei, M; Öllinger, R; Rad, R; Pichler, M; Kwong, LN Generation of An Endogenous FGFR2-BICC1 Gene Fusion/58 Megabase Inversion Using Single-Plasmid CRISPR/Cas9 Editing in Biliary Cells.
Int J Mol Sci. 2020; 21(7): 2460 Doi: 10.3390/ijms21072460 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Seidl, C; Panzitt, K; Bertsch, A; Brcic, L; Schein, S; Mack, M; Leithner, K; Prinz, F; Olschewski, H; Kornmueller, K; Hrzenjak, A MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
Cancer Lett. 2020; 469: 266-276. Doi: 10.1016/j.canlet.2019.10.044
Web of Science PubMed FullText FullText_MUG

 

** Stotz, M; Barth, DA; Riedl, JM; Asamer, E; Klocker, EV; Kornprat, P; Hutterer, GC; Prinz, F; Lackner, K; Stöger, H; Gerger, A; Pichler, M The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer.
Cancers (Basel). 2020; 12(7): Doi: 10.3390/cancers12071798 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Teppan, J; Barth, DA; Prinz, F; Jonas, K; Pichler, M; Klec, C Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis.
Noncoding RNA. 2020; 6(4): Doi: 10.3390/ncrna6040042 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

** Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoger, H; Pichler, M Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
CANCER RES. 2020; 80(4):-San Antonio Breast Cancer Symposium; DEC 10-14, 2019; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS19-P1-05-13 [Poster]
Web of Science FullText FullText_MUG

 

** Klec, C; Schwarzenbacher, D; Gottschalk, B; Margit, R; Prinz, F; Bauernhofer, T; Stoeger, H; Graier, WF; Pichler, M Deciphering the interplay between nuclear RNA export factors and long non-coding RNAs in breast cancer metabolism.
ANN ONCOL. ESMO Breast Cancer Virtual Meeting 2020. 2020; 31(S2):S38-S38.-ESMO Breast Cancer Virtual Meeting; MAY 23-24, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.03.202 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Jonas, K; Prinz, F; Klec, C; Pichler, M Characterization of Novel Non-Coding RNAs Potentially Involved in Breast Carcinogenesis and Tumor Cell Metabolism.
10th Scientific Retreat of the DK-MCD. 2020; -10th Scientific Retreat of the DK-MCD; SEP 28-29, 2020; Graz, AUSTRIA. [Oral Communication]

 

2019

Beiträge in Fachzeitschriften

** Klec, C; Prinz, F; Pichler, M Involvement of the long noncoding RNA NEAT1 in carcinogenesis.
Mol Oncol. 2019; 13(1):46-60 Doi: 10.1002/1878-0261.12404 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Prinz, F; Kapeller, A; Pichler, M; Klec, C The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases.
Int J Mol Sci. 2019; 20(3): Doi: 10.3390/ijms20030627 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Prinz, F; Calin, GA; Pichler, M Current concepts of non-coding RNA regulation of immune checkpoints in cancer.
Mol Aspects Med. 2019; 70:117-126 Doi: 10.1016/j.mam.2019.09.007
Web of Science PubMed FullText FullText_MUG

 

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Klec, C; Kapeller, A; Prinz, F; Trenk, C; Stoeger, H; Pichler, M Dissecting the interplay of the long non-coding RNA NORAD and PARP inhibitors in triple negative breast cancer.
San Antonio Breast Cancer Symposium. 2019; -SABCS; DEC 10-14; San Antonio, TX, USA. [Poster]

 

Klec, C; Schwarzenbacher, D; Gottschalk, B; Resel, M; Prinz, F; Heitzer, E; Bauernhofer, T; Stöger, H; Graier, WF; Pichler, M Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1
ÖGHO Frühjahrstagung 2019. 2019; -ÖGHO Frühjahrstagung 2019; 11.-13.April; Linz, AUSTRIA. [Poster]

 

Prinz, F; Reicher, A; Kiesslich, T; Klec, C; Gerger, A; Stoeger, H; Posch, F; Pichler, M Influence of epithelial-mesenchymal transition on immune checkpoints in biliary tract cancer
Doctoral Day of the Medical University Graz. 2019; -Doctoral Day of the Medical University Graz; NOV 21, 2019; Graz, AUSTRIA. [Poster]

 

Reicher, A; Prinz, F; Klec, C; Stoeger, H; Moik, F; Posch, F; Pichler, M Characterization of the fundamental role of fibroblast growth factor receptor 2 (FGFR2) gene fusions in carcinogenesis of intrahepatic cholangiocarcinoma using CRISPR/Cas9 genome engineering.
OEGHO- & AHOP-Frühjahrstagung 2019. 2019; -OeGHO- & AHOP-Frühjahrstagung 2019; 11.-13.April, 2019; Linz, AUSTRIA. [Poster]

 

Trenk, C; Prinz, F; Resel, M; Stoeger, H; Klec, C; Pichler, M miR-4520s as potential regulator of breast carcinogenesis
Doctoral Day 2019. 2019; -Doctoral Day 2019, Medical University of Graz; NOV 21, 2019; Graz, AUSTRIA. [Poster]

 

2018

Klec, C; Resel, M; Foßelteder, J; Prinz, F; Kapeller, A; Deutsch, A; Heitzer, E; Rinner, B; Stöger, H; Graier, WF; Pichler, M Paraspeckle-associated protein 1 (PAP1) controls breast cancer growth by regulating and interacting with the long non-coding RNA NEAT1.
Retrain the Brain. Doctoral Day 2018. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA. [Oral Communication]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum